Anthony Hunt is of REPLIGEN CORP. Currently has a direct ownership of 109,854 shares of RGEN, which is worth approximately $13.6 Million. The most recent transaction as insider was on May 15, 2025, when has been sold 26,447 shares (Common Stock) at a price of $124.55 per share, resulting in proceeds of $3,293,973. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 110K
19.4% 3M change
33.49% 12M change
Total Value Held $13.6 Million

Anthony Hunt Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 15 2025
SELL
Open market or private sale
$3,293,973 $124.55 p/Share
26,447 Reduced 19.4%
109,854 Common Stock
Mar 17 2025
SELL
Open market or private sale
$4,048,985 $151.33 p/Share
26,756 Reduced 16.41%
136,301 Common Stock
Mar 17 2025
BUY
Exercise of conversion of derivative security
$1,249,505 $46.7 p/Share
26,756 Added 14.1%
163,057 Common Stock
Mar 03 2025
SELL
Payment of exercise price or tax liability
$1,575,863 $155.38 p/Share
10,142 Reduced 6.93%
136,301 Common Stock
Feb 27 2025
SELL
Payment of exercise price or tax liability
$442,225 $156.54 p/Share
2,825 Reduced 1.89%
146,443 Common Stock
Feb 24 2025
SELL
Payment of exercise price or tax liability
$392,081 $164.74 p/Share
2,380 Reduced 1.57%
149,268 Common Stock
Dec 05 2024
BUY
Exercise of conversion of derivative security
$399,936 $33.87 p/Share
11,808 Added 7.22%
151,648 Common Stock
Nov 21 2024
SELL
Open market or private sale
$3,386,438 $139.67 p/Share
24,246 Reduced 14.78%
139,840 Common Stock
Nov 21 2024
BUY
Exercise of conversion of derivative security
$821,212 $33.87 p/Share
24,246 Added 12.87%
164,086 Common Stock
Sep 10 2024
SELL
Open market or private sale
$3,224,796 $145.32 p/Share
22,191 Reduced 13.7%
139,840 Common Stock
Sep 10 2024
BUY
Exercise of conversion of derivative security
$338,700 $33.87 p/Share
10,000 Added 5.81%
162,031 Common Stock
Sep 03 2024
SELL
Sale (or disposition) back to the issuer
-
13,146 Reduced 7.96%
152,031 Common Stock
Jun 14 2024
BUY
Open market or private purchase
$248,160 $124.08 p/Share
2,000 Added 1.2%
165,177 Common Stock
May 21 2024
SELL
Open market or private sale
$3,385,744 $168.68 p/Share
20,072 Reduced 10.95%
163,177 Common Stock
Mar 18 2024
SELL
Bona fide gift
-
2,000 Reduced 1.08%
183,249 Common Stock
Mar 08 2024
SELL
Open market or private sale
$3,325,027 $199.02 p/Share
16,707 Reduced 8.27%
185,249 Common Stock
Mar 08 2024
BUY
Exercise of conversion of derivative security
$16 $16.55 p/Share
1 Added 0.0%
201,956 Common Stock
Mar 07 2024
SELL
Payment of exercise price or tax liability
$561,129 $195.72 p/Share
2,867 Reduced 1.4%
201,955 Common Stock
Mar 05 2024
SELL
Payment of exercise price or tax liability
$1,422,408 $195.52 p/Share
7,275 Reduced 3.43%
204,822 Common Stock
Mar 04 2024
SELL
Payment of exercise price or tax liability
$215,522 $193.99 p/Share
1,111 Reduced 0.52%
212,097 Common Stock
Mar 01 2024
SELL
Payment of exercise price or tax liability
$637,126 $191.79 p/Share
3,322 Reduced 1.53%
213,208 Common Stock
Feb 29 2024
BUY
Grant, award, or other acquisition
-
2,504 Added 1.14%
216,530 Common Stock
Feb 27 2024
BUY
Grant, award, or other acquisition
-
19,719 Added 8.44%
214,026 Common Stock
Nov 14 2023
SELL
Bona fide gift
-
1,000 Reduced 0.51%
194,307 Common Stock
Mar 03 2023
SELL
Payment of exercise price or tax liability
$1,549,872 $188.0 p/Share
8,244 Reduced 4.05%
195,307 Common Stock

Also insider at

MASS
908 Devices Inc. Healthcare
BLFS
BIOLIFE SOLUTIONS INC Healthcare
AH

Anthony Hunt

Waltham, MA

Track Institutional and Insider Activities on RGEN

Follow REPLIGEN CORP and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RGEN shares.

Notify only if

Insider Trading

Get notified when an Repligen Corp insider buys or sells RGEN shares.

Notify only if

News

Receive news related to REPLIGEN CORP

Track Activities on RGEN